Kiora Pharmaceuticals' KIO-300 Shows Promise in Preclinical Epilepsy Model

Kiora Pharmaceuticals announced that its ion channel modulator KIO-300 significantly suppressed seizure activity in a preclinical temporal lobe epilep...